4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0000947871-22-000539
Director bought 125,359 shares at an average $1.57 ($197,252)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GORDON CARL L Director | 2022-05-06 | Purchase | +10,200 | $1.63 | $16,626 | 14,510,319 | I |
| GORDON CARL L Director | 2022-05-09 | Purchase | +90,712 | $1.56 | $141,511 | 14,601,031 | I |
| GORDON CARL L Director | 2022-05-10 | Purchase | +24,447 | $1.60 | $39,115 | 14,625,478 | I |
| Open-market purchases · 125,359 sh · avg $1.57 · $197,252 | |||||||
Loading xslF345X03/ownership.xml…